Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004232 · ClinicalTrials.gov registry record · Phase 1

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

A Phase 1 study of Lymphoma and Leukemia, sponsored by Northwestern University.

Completed
Registry status
Phase 1
Development phase
1
Study location

NCT00004232 is a Phase 1 study of Lymphoma and Leukemia that has completed, run by Northwestern University. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004232, a Phase 1 study of Lymphoma and Leukemia, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
Phase 1
Development phase
1
Study location

Study Summary

RATIONALE: Bone marrow and peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of bone marrow and peripheral stem cell transplantation in treating patients who have hematologic cancer.

Conditions Studied

Lymphoma Leukemia Myelodysplastic Syndromes Multiple Myeloma and Plasma Cell Neoplasm Graft-Versus-Host Disease Chronic Myeloproliferative Disorders Precancerous/Nonmalignant Condition

Interventions

  • DRUG prednisone
  • DRUG methylprednisolone
  • BIOLOGICAL filgrastim
  • PROCEDURE allogeneic bone marrow transplantation
  • DRUG cyclosporine

Study Locations (1)

Illinois

  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University - Chicago

Trial Details

FieldValue
Start Date 1999-10
Est. Completion 2002-10
Phase Phase 1

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00004232

The ClinicalTrials.gov registry entry for NCT00004232 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Lymphoma appearing as the primary indexed condition, and to 5 interventions - of which prednisone is the first listed.

NCT00004232 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00004232 about?

NCT00004232 is a clinical study titled "Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer". RATIONALE: Bone marrow and peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of bone marrow and peripheral stem cell transplantation in treatin...

What is the current status of trial NCT00004232?

This trial is currently completed. It is a Phase 1 study. The study started on 1999-10. Estimated completion is 2002-10.

What conditions does trial NCT00004232 study?

This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Plasma Cell Neoplasm, Graft-Versus-Host Disease.

What interventions are being tested in trial NCT00004232?

The interventions under investigation include: prednisone (DRUG), methylprednisolone (DRUG), filgrastim (BIOLOGICAL), allogeneic bone marrow transplantation (PROCEDURE), cyclosporine (DRUG).

Who is sponsoring clinical trial NCT00004232?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004232 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lymphoma

All registered trials for this condition

Leukemia

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.